–
Статьи в журналах
-
- 2021 Safety and efficacy of obinutuzumab alone or with chemotherapy in previously untreated or relapsed/refractory chronic lymphocytic leukaemia patients: Final analysis of the Phase IIIb GREEN study
- Stilgenbauer Stephan, Bosch Francesc, Ilhan Osman, Kisro Jens, Mahé Béatrice, Mikuskova Eva, Osmanov Dzhelil, Reda Gianluigi, Robinson Sue, Tausch Eugen, Turgut Mehmet, Wójtowicz Marcin, Böttcher Sebastian, Perretti Thomas, Trask Peter, Hoef Marlies Van, Leblond Véronique, Foà Robin
- в журнале British Journal of Haematology, издательство Blackwell Publishing Inc. (United Kingdom), том 193, № 2, с. 325-338 DOI